News

New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment outcomes for pediatric ...
What if a blood test could reveal the pace of our aging—and the diseases that may lie ahead? The labs of Profs. Liran Shlush ...
A new study shows that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...
A research team led by Associate Professor Ayako Okado-Matsumoto from the Department of Biology at Toho University has made a ...
Porton Advanced Solutions and EVA Pharma have signed an MoU to enhance the development capabilities for CAR T-cell therapies.
EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 70 countries worldwide. For more ...
Numerous businesses in Acadiana have come together for a benefit being held in support of a local boy, Fisher, and his family ...
Investigation reveals cancer drugs failing quality tests worldwide, including cisplatin, oxaliplatin, cyclophosphamide, ...
NeuroScientific Biopharmaceuticals has acquired unlisted Perth-based Isopogen for $5.1 million, gaining control of the ...
Despite major advances, real-world data show diminishing survival outcomes and treatment-limiting toxicities in second line ...
A Honduran woman filed a lawsuit challenging the legality of her and her family’s detention at a Texas facility. She is also ...